ProfileGDS4718 / 239832_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 84% 62% 87% 87% 70% 64% 77% 87% 84% 81% 88% 73% 70% 59% 74% 74% 67% 64% 70% 80% 78% 77% 82% 84% 69% 86% 75% 87% 67% 72% 58% 89% 83% 50% 60% 74% 85% 81% 49% 77% 76% 67% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9883588
GSM549102patient 115, normal, homogenized [OPG study]8.213884
GSM549104patient 119, normal, homogenized [OPG study]6.291862
GSM549108patient 138, normal, homogenized [OPG study]8.6269987
GSM549119patient 077, normal, homogenized [OPG study]8.7128587
GSM549133patient 032, cancer, homogenized [OPG study]6.8972170
GSM549139patient 042, cancer, homogenized [OPG study]6.3948464
GSM549099patient 107, normal, homogenized [OPG study]7.5005177
GSM549109patient 139, normal, homogenized [OPG study]8.744787
GSM549110patient 046, normal, homogenized [OPG study]8.3871484
GSM549114patient 063, normal, homogenized [OPG study]8.0519581
GSM549122patient 082, normal, homogenized [OPG study]8.8766288
GSM549134patient 033, cancer, homogenized [OPG study]7.1327773
GSM549136patient 036, cancer, homogenized [OPG study]6.9340970
GSM549140patient 044, cancer, homogenized [OPG study]6.0564759
GSM549111patient 047, normal, homogenized [OPG study]7.3225874
GSM549113patient 057, normal, homogenized [OPG study]7.231274
GSM549132patient 031, cancer, homogenized [OPG study]6.6758367
GSM549137patient 038, cancer, homogenized [OPG study]6.4450664
GSM549142patient 047, cancer, homogenized [OPG study]6.8580670
GSM549100patient 110, normal, homogenized [OPG study]7.8045580
GSM549107patient 135, normal, homogenized [OPG study]7.6784478
GSM549115patient 068, normal, homogenized [OPG study]7.6637877
GSM549116patient 072, normal, homogenized [OPG study]8.1057282
GSM549120patient 078, normal, homogenized [OPG study]8.3104984
GSM549131patient 030, cancer, homogenized [OPG study]6.834369
GSM549118patient 074, normal, homogenized [OPG study]8.7017186
GSM549129patient 027, cancer, homogenized [OPG study]7.3998775
GSM549123patient 088, normal, homogenized [OPG study]8.6997587
GSM549124patient 006, cancer, homogenized [OPG study]6.6181267
GSM549126patient 015, cancer, homogenized [OPG study]7.0134872
GSM549128patient 025, cancer, homogenized [OPG study]6.0015358
GSM549103patient 117, normal, homogenized [OPG study]8.9189489
GSM549117patient 073, normal, homogenized [OPG study]8.2561483
GSM549138patient 041, cancer, homogenized [OPG study]5.5315350
GSM549141patient 045, cancer, homogenized [OPG study]6.1225360
GSM549130patient 028, cancer, homogenized [OPG study]7.1713474
GSM549101patient 111, normal, homogenized [OPG study]8.4556285
GSM549105patient 128, normal, homogenized [OPG study]7.9016981
GSM549106patient 134, normal, homogenized [OPG study]5.432849
GSM549112patient 048, normal, homogenized [OPG study]7.482577
GSM549125patient 011, cancer, homogenized [OPG study]7.4204776
GSM549127patient 024, cancer, homogenized [OPG study]6.6683567
GSM549135patient 035, cancer, homogenized [OPG study]5.6367453